Patients #/sex/age in years	Response to CAR T-cell therapy at one month	Onset of Nivo after CAR T-cell infusion (days)	Number of injections	Main side effects	Response to Nivo	Current Nivo	Treatment after Nivo	Current status and survival after CAR T-cell therapy (days)
1/M/59	PR	86	5	psoriasis	CR	stopped	Allo-HCT	Alive 354
2/M/39	PR	133	4	-	PD	stopped	Allo-HCT	Died 306
3/F/63	SD	83	5	-	PD	stopped	Supportive care	Alive 275
4/F/69	PR	144	5	pneumonia	CR	ongoing	-	Alive 227
5/F/53	PD	37	5	-	PD	stopped	Ibrutinib lenalidomide	Alive 220
6/F/63	PD	51	9	pneumonia	PR	ongoing	-	Alive 179
7/M/55	SD	60	2	-	PD	stopped	Supportive care	Died 150
8/F/74	SD	46	4	pneumonia	PD	stopped	Supportive care	Alive 153
9/F/67	PD	39	3	-	ongoing	ongoing	-	Alive 76

[Table1. Patients’ outcome after Nivo administration]